iQone Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
20
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
- Investments
-
1
iQone General Information
Description
Operator of a specialty pharmaceutical company focusing on commercializing biosimilars, orphan drugs and oncology products. The company provides treatments and medicines for patients and surgeons in the bones and tissues, oncology, hematology, rheumatology, and gastroenterology therapeutic, enabling them to get access to specialized therapeutics that address serious medical conditions.
Contact Information
Website
www.iqone-healthcare.com(Operating Subsidiary)
Corporate Office
- Modulis Business Park
- Route de Suisse 162
- 1290 Versoix
- Switzerland
Corporate Office
- Modulis Business Park
- Route de Suisse 162
- 1290 Versoix
- Switzerland
iQone Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
iQone Comparisons
Industry
Financing
Details
iQone Competitors (59)
One of iQone’s 59 competitors is Pfizer (Vienna), a Corporation company based in Vienna, Austria.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Pfizer (Vienna) | Corporation | Vienna, Austria | ||||
| Pfizer Pakistan | Corporation | Karachi, Pakistan | ||||
| STADA ANZ | Corporation | Sydney, Australia | ||||
| Regeneron Pharmaceuticals | Formerly VC-backed | Tarrytown, NY | ||||
| Evonile Pharma | Private Equity-Backed | Mumbai, India |
iQone Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
iQone Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
iQone Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
iQone Acquisitions (1)
iQone’s most recent deal was a Merger/Acquisition with Advanz Pharma (Distribution of Biosimilar Portfolio Unit). The deal was made on 27-Oct-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Advanz Pharma (Distribution of Biosimilar Portfolio Unit) | 27-Oct-2026 | Merger/Acquisition | Pharmaceuticals |
iQone FAQs
-
When was iQone founded?
iQone was founded in 2013.
-
Where is iQone headquartered?
iQone is headquartered in Versoix, Switzerland.
-
What is the size of iQone?
iQone has 20 total employees.
-
What industry is iQone in?
iQone’s primary industry is Pharmaceuticals.
-
Is iQone a private or public company?
iQone is a Private company.
-
What is the current valuation of iQone?
The current valuation of iQone is .
-
What is iQone’s current revenue?
The current revenue for iQone is .
-
Who are iQone’s investors?
Clinigen has invested in iQone.
-
Who are iQone’s competitors?
Pfizer (Vienna), Pfizer Pakistan, STADA ANZ, Regeneron Pharmaceuticals, and Evonile Pharma are some of the 59 competitors of iQone.
-
When was iQone acquired?
iQone was acquired on 15-Nov-2024.
-
Who acquired iQone?
iQone was acquired by Celltrion.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
